Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
01 Jul 2015 European Medicines Agency Recommends a New Indication for Pertuzumab Breast cancer - Anticancer agents & Biologic therapy
30 Jun 2015 European Medicines Agency Recommends Granting a Marketing Authorisation for Sonidegib Anticancer agents & Biologic therapy
29 Jun 2015 First HDAC Inhibitor for Treatment of Multiple Myeloma Recommended for Approval in EU Haematologic malignancies - Anticancer agents & Biologic therapy
24 Jun 2015 Targeted Treatment for Hypoxic Conditions Translational research
23 Jun 2015 Four Distinct Genomic Subtypes of Cutaneous Melanoma Translational research - Melanoma
22 Jun 2015 European Commission Approves Nivolumab, for Both First-Line and Previously Treated Patients With Advanced Melanoma Melanoma - Immuno-oncology
10 Jun 2015 Therapeutic Dual Inhibition of HER2 Pathway in the HERACLES Trial Personalised medicine - Gastrointestinal cancers - Anticancer agents & Biologic therapy
09 Jun 2015 PALOMA3 Results Show that Palbociclib in Combination With Fulvestrant Could Offer an Effective and Less Toxic Treatment Option for Endocrine-Resistant Metastatic Breast Cancer Breast cancer - Anticancer agents & Biologic therapy
08 Jun 2015 Liver-Directed Therapy With SIRT, Using Y-90 Resin Microspheres, Plus FOLFOX-Based First-Line Chemotherapy for mCRC Gastrointestinal cancers
02 Jun 2015 Nivolumab vs Docetaxel in Advanced Non-Squamous Cell NSCLC Lung and other thoracic tumours - Immuno-oncology - Anticancer agents & Biologic therapy
30 May 2015 ESMO Press Release: ESMO Announces a Scale to Stratify the Magnitude of Clinical Benefit of Anti-Cancer Medicines
28 May 2015 European Medicines Agency Recommends Granting a Marketing Authorisation for Generic Bortezomib Haematologic malignancies - Anticancer agents & Biologic therapy
27 May 2015 European Medicines Agency Recommends Granting a Marketing Authorisation for Dinutiximab Cancer in Special Situations - Immuno-oncology
26 May 2015 European Medicines Agency Issues Positive Recommendation for a New Therapeutic Indication for Ibrutinib Haematologic malignancies - Anticancer agents & Biologic therapy
22 May 2015 The European Medicines Agency Recommends Granting a Marketing Authorisation for Pembrolizumab Melanoma - Immuno-oncology